News
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
3 November 2025
Biomodulation protocols ACT, CO and MO based on REAC® Technology presented at the congress.
27 May 2023
A clinical trial evaluates the REAC NPO and NPPO protocols on mobility and quality of life in patients with fibromyalgia syndrome.
Reserved access
Access to the display of medical devices and information material is reserved for operators in the sector, in compliance with current legislation.
By continuing to browse, I declare that I am a healthcare professional.
EnterFor information on treatments you can contact the Rinaldi Fontani Institute in Florence.
Go to irf.itLegislative Decree No 46 of 24 February 1997 — Article 21